Published in Cancer on March 01, 2010
Impact of Completion Lymph Node Dissection on Patients with Positive Sentinel Lymph Node Biopsy in Melanoma. J Am Coll Surg (2016) 0.88
Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009). BMC Dermatol (2012) 0.80
Risk evaluation in cutaneous melanoma patients undergoing lymph node dissection: impact of POSSUM. Ann R Coll Surg Engl (2011) 0.79
SLN melanoma micrometastasis predictivity of nodal status: a long term retrospective study. J Exp Clin Cancer Res (2013) 0.76
False-positivity in the sentinel lymph nodes in melanoma and breast cancer. Cancer (2010) 0.75
The persistent anchor of lymph node removal in patients with melanoma. Cancer (2010) 0.75
Update and Review on the Surgical Management of Primary Cutaneous Melanoma. Healthcare (Basel) (2014) 0.75
Adjuvant chemotherapy after potentially curative resection of metastases from colorectal cancer: a pooled analysis of two randomized trials. J Clin Oncol (2008) 3.49
Systematic review and meta-analysis of studies reporting oncologic outcome after robot-assisted radical prostatectomy. Eur Urol (2012) 3.26
Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era? J Clin Oncol (2007) 3.15
A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg (2008) 3.14
IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients. J Immunol (2009) 2.64
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Interferon alpha adjuvant therapy in patients with high-risk melanoma: a systematic review and meta-analysis. J Natl Cancer Inst (2010) 2.56
Local excision after preoperative chemoradiotherapy for rectal cancer: results of a multicenter phase II clinical trial. Dis Colon Rectum (2013) 2.52
The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis. Clin Cancer Res (2006) 2.36
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg (2010) 2.27
Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness. Cancer Res (2002) 2.21
Postoperative adjuvant chemotherapy in rectal cancer operated for cure. Cochrane Database Syst Rev (2012) 2.05
cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted. J Clin Oncol (2008) 1.93
Quantitative real-time PCR: a powerful ally in cancer research. Trends Mol Med (2003) 1.88
Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis. J Natl Cancer Inst (2012) 1.82
Relationship between pathologic T-stage and nodal metastasis after preoperative chemoradiotherapy for locally advanced rectal cancer. Ann Surg Oncol (2005) 1.79
Gastrointestinal stromal tumors: from a surgical to a molecular approach. Int J Cancer (2003) 1.77
The activity and safety of electrochemotherapy in persistent chest wall recurrence from breast cancer after mastectomy: a phase-II study. Breast Cancer Res Treat (2012) 1.77
Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol (2003) 1.75
Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis. Ann Surg Oncol (2011) 1.69
Bleomycin-based electrochemotherapy: clinical outcome from a single institution's experience with 52 patients. Ann Surg Oncol (2008) 1.65
Part I: Vaccines for solid tumours. Lancet Oncol (2004) 1.61
Nitric oxide, a double edged sword in cancer biology: searching for therapeutic opportunities. Med Res Rev (2007) 1.55
Hyperthermic isolated limb perfusion with low-dose tumor necrosis factor-alpha and melphalan for bulky in-transit melanoma metastases. Ann Surg Oncol (2004) 1.55
Automated quantitative evaluation of lymph node perfusion on contrast-enhanced sonography. AJR Am J Roentgenol (2007) 1.55
Tumor necrosis factor, cancer and anticancer therapy. Cytokine Growth Factor Rev (2004) 1.55
Contrast-enhanced ultrasound for characterizing lymph nodes with focal cortical thickening in patients with cutaneous melanoma. AJR Am J Roentgenol (2011) 1.55
The impact of lymphoscintigraphy technique on the outcome of sentinel node biopsy in 1,313 patients with cutaneous melanoma: an Italian Multicentric Study (SOLISM-IMI). J Nucl Med (2006) 1.53
Multivisceral resection for locally advanced gastric cancer: an Italian multicenter observational study. JAMA Surg (2013) 1.53
Targetlike appearance of pseudotumors in segment IV of the liver on sonography. AJR Am J Roentgenol (2002) 1.52
Circulating tumor cells: the 'leukemic phase' of solid cancers. Trends Mol Med (2006) 1.51
Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status. J Natl Cancer Inst (2006) 1.51
Telomerase and the search for the end of cancer. Trends Mol Med (2012) 1.46
Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma. Int J Cancer (2005) 1.46
Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res (2008) 1.42
Lymphatic biomarkers in primary melanomas as predictors of regional lymph node metastasis and patient outcomes. Pigment Cell Melanoma Res (2013) 1.41
Randomized trial of intraportal and/or systemic adjuvant chemotherapy in patients with colon carcinoma. J Natl Cancer Inst (2004) 1.39
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis. BMC Genomics (2013) 1.39
Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Ann Surg Oncol (2009) 1.36
The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle. Cytokine Growth Factor Rev (2004) 1.34
Complementary techniques: validation of gene expression data by quantitative real time PCR. Adv Exp Med Biol (2007) 1.32
EUS for the staging of gastric cancer: a meta-analysis. Gastrointest Endosc (2011) 1.27
Giant fibroadenoma of the breast in adolescents: report of 2 cases. J Pediatr Surg (2009) 1.24
Identification of immune dominant cytomegalovirus epitopes using quantitative real-time polymerase chain reactions to measure interferon-gamma production by peptide-stimulated peripheral blood mononuclear cells. J Immunother (2002) 1.17
Patient-reported outcomes after neoadjuvant chemoradiotherapy for rectal cancer: a multicenter prospective observational study. Ann Surg (2011) 1.16
Bisphosphonate-associated jawbone osteonecrosis: a correlation between imaging techniques and histopathology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (2008) 1.15
TNF and cancer: the two sides of the coin. Front Biosci (2008) 1.15
Tumor size and effectiveness of electrochemotherapy. Radiol Oncol (2013) 1.14
A gene expression signature associated with survival in metastatic melanoma. J Transl Med (2006) 1.13
Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol (2006) 1.12
Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res (2008) 1.11
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer. Ann Surg Oncol (2007) 1.10
Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing. Lab Invest (2010) 1.09
The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem (2010) 1.08
Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev (2005) 1.08
Tumor necrosis factor (TNF) biology and cell death. Front Biosci (2008) 1.07
Primary inverted papilloma of the middle ear and mastoid. Otol Neurotol (2002) 1.07
The potential of restaging in the prediction of pathologic response after preoperative chemoradiotherapy for rectal cancer. Ann Surg Oncol (2006) 1.07
Prospective assessment of imaging after preoperative chemoradiotherapy for rectal cancer. Surgery (2010) 1.07
-174 G>C polymorphism of interleukin 6 gene promoter affects interleukin 6 serum level in patients with colorectal cancer. Clin Cancer Res (2003) 1.05
The prognostic value of serum S100B in patients with cutaneous melanoma: a meta-analysis. Int J Cancer (2008) 1.04
Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res (2002) 1.04
Vitamin D receptor polymorphisms and the risk of cutaneous melanoma: a systematic review and meta-analysis. Cancer (2008) 1.04
Evaluation of lymph node perfusion using continuous mode harmonic ultrasonography with a second-generation contrast agent. J Ultrasound Med (2004) 1.02
Helicobacter pylori, inflammation, oxidative damage and gastric cancer: a morphological, biological and molecular pathway. Eur J Cancer Prev (2008) 1.02
Ex vivo screening for immunodominant viral epitopes by quantitative real time polymerase chain reaction (qRT-PCR). J Transl Med (2003) 1.01
Gastric cancer and synchronous hepatic metastases: is it possible to recognize candidates to R0 resection? Ann Surg Oncol (2014) 1.01
Literature search on risk factors for sarcoma: PubMed and Google Scholar may be complementary sources. BMC Res Notes (2010) 1.01
Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker. Clin Colorectal Cancer (2009) 1.00
The HER2-miR125a5p/miR125b loop in gastric and esophageal carcinogenesis. Hum Pathol (2013) 1.00
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin. Surg Oncol Clin N Am (2003) 1.00
Precancerous lesions in the stomach: from biology to clinical patient management. Best Pract Res Clin Gastroenterol (2013) 0.99
DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Carcinogenesis (2009) 0.99
Survivin gene levels in the peripheral blood of patients with gastric cancer independently predict survival. J Transl Med (2009) 0.99
Suppressive influences in the immune response to cancer. J Immunother (2009) 0.99
Early HER2 dysregulation in gastric and oesophageal carcinogenesis. Histopathology (2012) 0.98
Sentinel node status prediction by four statistical models: results from a large bi-institutional series (n = 1132). Ann Surg (2009) 0.97
Cancer vaccines: pessimism in check. Nat Med (2004) 0.97
Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma. Int J Cancer (2004) 0.96